{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:21:42Z","timestamp":1767990102453,"version":"3.49.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.fjurol.2025.102960","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T21:34:23Z","timestamp":1763588063000},"page":"102960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kidney transplantation from donors with cancer or history of cancer: Transplantation and cancerology committee of Association Fran\u00e7aise d\u2019Urologie guidelines (CTAFU\/CCAFU)"],"prefix":"10.1016","volume":"35","author":[{"given":"Sarah J.","family":"Drouin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Goujon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Defortescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4455-9538","authenticated-orcid":false,"given":"Alexandre","family":"Frontczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bess\u00e8de","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Prudhomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Sallusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Alezra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9gory","family":"Verhoest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanish","family":"Soorojebally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Ploussard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Bigot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zine-Eddine","family":"Khene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla","family":"Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-146X","authenticated-orcid":false,"given":"Mathieu","family":"Roumigui\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Neuville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7211-9180","authenticated-orcid":false,"given":"Agate","family":"Escoffier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre Olivier","family":"Delpech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2751-4111","authenticated-orcid":false,"given":"Emilien Seizilles de","family":"Mazancourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cille","family":"Champy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Branchereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9489-3722","authenticated-orcid":false,"given":"Marine","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Roupret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Kleinclauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Olivier","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Boissier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7836-7633","authenticated-orcid":false,"given":"Thibaut","family":"Culty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fjurol.2025.102960_bib0530","unstructured":"Agence de la biom\u00e9decine. Le rapport m\u00e9dical et scientifique du pr\u00e9l\u00e8vement et de la greffe en France. Rapport 2024. Available at: https:\/\/rams.agence-biomedecine.fr\/organes. Accessed July 27, 2025."},{"key":"10.1016\/j.fjurol.2025.102960_bib0535","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/TP.0b013e318272df41","article-title":"Cancer transmission from organ donors-unavoidable but low risk","volume":"94","author":"Desai","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0540","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/TP.0b013e31816c2f55","article-title":"The Spanish National Transplant Organization (ONT) tumor registry","volume":"85","author":"Garrido","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0545","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/ajt.16178","article-title":"Ten years of donor-derived disease: a report of the Disease Transmission Advisory Committee","volume":"21","author":"Kaul","year":"2021","journal-title":"Am J Transpl"},{"key":"10.1016\/j.fjurol.2025.102960_bib0550","doi-asserted-by":"crossref","first-page":"10092","DOI":"10.3389\/ti.2021.10092","article-title":"Donor-transmitted cancer in orthotopic solid organ transplant recipients: a systematic review","volume":"35","author":"Greenhall","year":"2021","journal-title":"Transpl Int"},{"key":"10.1016\/j.fjurol.2025.102960_bib0555","doi-asserted-by":"crossref","first-page":"e0271293","DOI":"10.1371\/journal.pone.0271293","article-title":"Donor-derived urologic cancers after renal transplantation: a retrospective non-randomized scientific analysis","volume":"17","author":"Hellstrom","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.fjurol.2025.102960_bib0560","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1600-6143.2011.03565.x","article-title":"Donor-transmitted malignancies in organ transplantation: assessment of clinical risk","volume":"11","author":"Nalesnik","year":"2011","journal-title":"Am J Transpl"},{"key":"10.1016\/j.fjurol.2025.102960_bib0565","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.transproceed.2012.06.030","article-title":"The use of neoplastic donors to increase the donor pool","volume":"44","author":"Fiaschetti","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.fjurol.2025.102960_bib0570","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1600-6143.2010.03130.x","article-title":"How safe is it to transplant organs from deceased donors with primary intracranial malignancy? An analysis of UK Registry data","volume":"10","author":"Watson","year":"2010","journal-title":"Am J Transpl"},{"key":"10.1016\/j.fjurol.2025.102960_bib0575","unstructured":"Advisory Committee on the Safety of Blood Tissues and Organs (SaBTO). Transplantation of organs from deceased donors with cancer or a history of cancer. Published 22 April 2014. Last updated 24 December 2020. Available at https:\/\/www.gov.uk\/government\/publications\/transplantation-of-organs-from-donors-with-a-history-of-cancer. Accessed August 8, 2024."},{"key":"10.1016\/j.fjurol.2025.102960_bib0580","unstructured":"The Transplantation Society of Australia and New Zealand. Version 1.13. Clinical guidelines for organ transplantation from deceased donors. Available at https:\/\/tsanz.com.au\/guidelinesethics-documents\/tsanz-clinical-guidelines.htm. Accessed August 8, 2024."},{"key":"10.1016\/j.fjurol.2025.102960_bib0585","doi-asserted-by":"crossref","first-page":"e1252","DOI":"10.1097\/TXD.0000000000001252","article-title":"Perceived versus verified cancer history and missed opportunities for donation in an Australian cohort of potential deceased solid organ donors","volume":"8","author":"Hedley","year":"2022","journal-title":"Transplant Direct"},{"key":"10.1016\/j.fjurol.2025.102960_bib0590","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.tp.0000267919.93425.fb","article-title":"Deceased donors with a past history of malignancy: an organ procurement and transplantation network\/united network for organ sharing update","volume":"84","author":"Kauffman","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0595","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.transproceed.2004.12.118","article-title":"Donor kidneys with small renal cell cancers: can they be transplanted?","volume":"37","author":"Buell","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.fjurol.2025.102960_bib0600","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/TP.0000000000000584","article-title":"Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee","volume":"99","author":"Green","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0605","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00007890-200211270-00012","article-title":"Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors","volume":"74","author":"Birkeland","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.purol.2020.03.016","article-title":"[Editorial: The French Guidelines from CTAFU, narrative or systematic review?.]","volume":"31","author":"Timsit","year":"2021","journal-title":"Prog Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0615","unstructured":"HAS. 2020. Guide m\u00e9thodologique\u00a0: \u00c9laboration de recommandations de bonne pratique - M\u00e9thode \u00ab\u00a0Recommandations pour la pratique clinique\u00a0\u00bb. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2020-02\/reco363_gm_rbp_maj_janv_2020_cd_2020_01_22_v0.pdf."},{"key":"10.1016\/j.fjurol.2025.102960_bib0620","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/jama.1997.03540260047034","article-title":"Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation","volume":"277","author":"Loh","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.fjurol.2025.102960_bib0625","doi-asserted-by":"crossref","first-page":"378","DOI":"10.14309\/ajg.0000000000000135","article-title":"Periesophageal lymph node metastasis of prostate adenocarcinoma from liver transplant donor","volume":"114","author":"S\u00e1nchez-Montes","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0630","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.transproceed.2012.06.005","article-title":"Donors with malignancies-risk or chance?","volume":"44","author":"Giessing","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.fjurol.2025.102960_bib0635","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.trre.2015.06.001","article-title":"Renal donors with prostate cancer, no longer a reason to decline","volume":"30","author":"Dholakia","year":"2016","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.fjurol.2025.102960_bib0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trre.2013.10.003","article-title":"Prostate cancer in deceased organ donors: a review","volume":"28","author":"Doerfler","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.fjurol.2025.102960_bib0645","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/pros.10177","article-title":"Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study","volume":"54","author":"S\u00e1nchez-Chapado","year":"2003","journal-title":"The Prostate"},{"key":"10.1016\/j.fjurol.2025.102960_bib0650","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.juro.2007.10.057","article-title":"Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors","volume":"179","author":"Yin","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0655","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0660","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s40620-018-00573-z","article-title":"How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network","volume":"32","author":"Eccher","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0665","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.transproceed.2018.03.036","article-title":"Follow-up survey of donor candidates for living related kidney transplantation with prostate cancer","volume":"50","author":"Hata","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.fjurol.2025.102960_bib0670","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.transproceed.2024.03.007","article-title":"The prevalence of prostate cancer in organ donors with increased prostate-specific antigen","volume":"56","author":"Bzoma","year":"2024","journal-title":"Transplant Proc"},{"key":"10.1016\/j.fjurol.2025.102960_bib0675","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1166-7087(07)92301-5","article-title":"[Evaluation of serum PSA in brain-dead subjects over the age of 50 before organ harvesting: organ donation and the risk of transmission of prostate cancer. Survey of the transplantation committee of the Association Francaise d\u2019Urologie]","volume":"17","author":"Salomon","year":"2007","journal-title":"Prog Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0680","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.transproceed.2015.12.142","article-title":"Prostate specific antigen-positive deceased organ donor: a pathologist is indispensable","volume":"48","author":"Pabisiak","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.fjurol.2025.102960_bib0685","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.prp.2008.10.004","article-title":"Intraoperative examination for suspected prostatic carcinoma: frozen sections in \u201cmarginal\u201d (cadaveric) transplant donors","volume":"205","author":"Falconieri","year":"2009","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.fjurol.2025.102960_bib0690","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/TP.0000000000004984","article-title":"Cost-effectiveness of accepting kidneys from deceased donors with common cancers-a modeling study","volume":"108","author":"Shah","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0695","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/01.TP.0000092306.29395.96","article-title":"A multiorgan donor cancer screening protocol: the Italian Emilia-Romagna region experience","volume":"76","author":"Fiorentino","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0700","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/01.TP.0000136989.87896.A4","article-title":"A histopathologic screening method for rational use of organs from prostate-specific antigen-positive multiorgan donors: the Italian Emilia-Romagna Region experience","volume":"78","author":"D\u2019Errico Grigioni","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0705","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/j.1600-6143.2010.03198.x","article-title":"Expanding the criteria of organ procurement from donors with prostate cancer: the application of the new Italian guidelines","volume":"10","author":"D\u2019Errico-Grigioni","year":"2010","journal-title":"Am J Transpl"},{"key":"10.1016\/j.fjurol.2025.102960_bib0710","series-title":"Guide to the quality and safety of organs for transplantation","year":"2022"},{"key":"10.1016\/j.fjurol.2025.102960_bib0715","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","article-title":"Renal cell carcinoma","volume":"373","author":"Rini","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.fjurol.2025.102960_bib0720","doi-asserted-by":"crossref","first-page":"102735","DOI":"10.1016\/j.fjurol.2024.102735","article-title":"Cancer Committee Guidelines - Update 2024-2026: Management of kidney cancer","volume":"34","author":"Bigot","year":"2024","journal-title":"Fr J Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0725","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/00007890-199906150-00008","article-title":"The incidence and implications of renal cell carcinoma in cadaveric renal transplants at the time of organ recovery","volume":"67","author":"Carver","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0730","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.19.00107","article-title":"Predicting renal cancer recurrence: defining limitations of existing prognostic models with prospective trial-based validation","volume":"37","author":"Correa","year":"2019","journal-title":"JCO"},{"key":"10.1016\/j.fjurol.2025.102960_bib0735","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.euros.2021.09.004","article-title":"External validation of the ASSURE model for predicting oncological outcomes after resection of high-risk renal cell carcinoma (RESCUE Study: UroCCR 88)","volume":"33","author":"Khene","year":"2021","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.fjurol.2025.102960_bib0740","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/bju.15959","article-title":"Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR 15)","volume":"132","author":"Boulenger De Hauteclocque","year":"2023","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2025.102960_bib0745","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","article-title":"European Association of Urology Guidelines on renal cell carcinoma: the 2022 update","volume":"82","author":"Ljungberg","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0750","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1200\/JCO.2004.09.104","article-title":"Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study","volume":"22","author":"Patard","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0755","doi-asserted-by":"crossref","first-page":"167.e1","DOI":"10.1016\/j.urolonc.2021.11.025","article-title":"Risk of recurrence after nephrectomy: comparison of predictive ability of validated risk models","volume":"40","author":"Palumbo","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0760","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1111\/ajt.12430","article-title":"Donor cancer transmission in kidney transplantation: a systematic review","volume":"13","author":"Xiao","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.fjurol.2025.102960_bib0765","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.euf.2018.01.018","article-title":"Effectiveness and harms of using kidneys with small renal tumors from deceased or living donors as a source of renal transplantation: a systematic review","volume":"5","author":"Hevia","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.fjurol.2025.102960_bib0770","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s40620-020-00775-4","article-title":"Donor-transmitted cancer in kidney transplant recipients: a systematic review","volume":"33","author":"Eccher","year":"2020","journal-title":"J Nephrol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0775","article-title":"Transplanting kidneys from donors with small renal masses - a strategy to expand the donor pool","volume":"14","author":"Cristea","year":"2020","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.fjurol.2025.102960_bib0780","doi-asserted-by":"crossref","first-page":"e70020","DOI":"10.1111\/ctr.70020","article-title":"Kidney transplantation from donors with malignant renal masses: a systematic review","volume":"38","author":"Villani","year":"2024","journal-title":"Clin Transpl"},{"key":"10.1016\/j.fjurol.2025.102960_bib0785","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/UA.UA_14_20","article-title":"Use and outcomes of kidneys from donors with renal angiomyolipoma: A systematic review","volume":"13","author":"Anton","year":"2021","journal-title":"Urol Ann"},{"key":"10.1016\/j.fjurol.2025.102960_bib0790","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MOU.0b013e328349638e","article-title":"Kidneys from patients with small renal tumours used for transplantation: outcomes and results","volume":"21","author":"Nicol","year":"2011","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0795","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-6143.2011.03794.x","article-title":"The use of kidneys with small renal tumors for transplantation: who is taking the risk?","volume":"12","author":"Flechner","year":"2012","journal-title":"Am J Transpl"},{"key":"10.1016\/j.fjurol.2025.102960_bib0800","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40620-015-0249-2","article-title":"Transplantation of kidneys with tumors","volume":"29","author":"Frasc\u00e0","year":"2016","journal-title":"J Nephrol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0805","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11934-015-0557-z","article-title":"Use of kidneys with small renal tumors for transplantation","volume":"17","author":"Lugo-Baruqui","year":"2016","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.fjurol.2025.102960_bib0810","doi-asserted-by":"crossref","first-page":"487","DOI":"10.23876\/j.krcp.20.050","article-title":"Pathological features and outcomes of incidental renal cell carcinoma in candidate solid organ donors","volume":"39","author":"Ambrosi","year":"2020","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.fjurol.2025.102960_bib0815","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1432-2277.2009.01002.x","article-title":"Outcomes of transplants from patients with small renal tumours, live unrelated donors and dialysis wait-listed patients: transplant outcomes after removal of renal tumours","volume":"23","author":"Brook","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.fjurol.2025.102960_bib0820","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.transproceed.2012.12.018","article-title":"Restored kidney graft from urologist referrals for renal transplantation","volume":"45","author":"He","year":"2013","journal-title":"Transpl Proc"},{"key":"10.1016\/j.fjurol.2025.102960_bib0825","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/tri.12594","article-title":"Living donor renal transplantation with incidental renal cell carcinoma from donor allograft","volume":"28","author":"Lugo-Baruqui","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.fjurol.2025.102960_bib0830","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1600-6143.2007.02145.x","article-title":"Last resort for renal transplant recipients, \u2018restored kidneys\u2019 from living donors\/patients","volume":"8","author":"Mannami","year":"2008","journal-title":"Am J Transpl"},{"key":"10.1016\/j.fjurol.2025.102960_bib0835","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/TP.0b013e3182875e00","article-title":"Kidneys from donors with incidental renal tumors: should they be considered acceptable option for transplantation?","volume":"95","author":"Musquera","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0840","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1464-410X.2008.07562.x","article-title":"Kidneys from patients with small renal tumours: a novel source of kidneys for transplantation","volume":"102","author":"Nicol","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2025.102960_bib0845","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/tri.12693","article-title":"Transplantation of liver and kidney from donors with malignancy at the time of donation: an experience from a single centre","volume":"29","author":"Pandanaboyana","year":"2016","journal-title":"Transplant Int"},{"key":"10.1016\/j.fjurol.2025.102960_bib0850","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1464-410X.2009.08681.x","article-title":"Living-donor renal transplantation of grafts with incidental renal masses after ex-vivo partial nephrectomy","volume":"104","author":"Sener","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2025.102960_bib0855","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1097\/TXD.0000000000000946","article-title":"Assessment of restored kidney transplantation including the use of wider criteria for accepting renal donors after cancer excision","volume":"5","author":"Sprott","year":"2019","journal-title":"Transpl Direct"},{"key":"10.1016\/j.fjurol.2025.102960_bib0860","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.transproceed.2012.06.036","article-title":"Organ donors with small renal cancer: report of 3 cases","volume":"44","author":"Valente","year":"2012","journal-title":"Transpl Proc"},{"key":"10.1016\/j.fjurol.2025.102960_bib0865","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.transproceed.2017.12.006","article-title":"Kidneys with small renal cell carcinoma used in transplantation after ex vivo partial nephrectomy","volume":"50","author":"Wang","year":"2018","journal-title":"Transpl Proc"},{"key":"10.1016\/j.fjurol.2025.102960_bib0870","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/bjs.9460","article-title":"Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry","volume":"101","author":"Desai","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.fjurol.2025.102960_bib0875","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/00007890-200212270-00001","article-title":"Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation","volume":"74","author":"Feng","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0880","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1600-6143.2009.02700.x","article-title":"Donor-derived disease transmission events in the United States: data reviewed by the OPTN\/UNOS Disease Transmission Advisory Committee","volume":"9","author":"Ison","year":"2009","journal-title":"Am J Transpl"},{"key":"10.1016\/j.fjurol.2025.102960_bib0885","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-6143.2011.03493.x","article-title":"An update on donor-derived disease transmission in organ transplantation","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transpl"},{"key":"10.1016\/j.fjurol.2025.102960_bib0890","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00007890-200012270-00014","article-title":"First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer","volume":"70","author":"Kauffman","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0895","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/TP.0b013e31816c2f05","article-title":"Quality and safety in the Italian donor evaluation process","volume":"85","author":"Nanni Costa","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0900","doi-asserted-by":"crossref","first-page":"e13597","DOI":"10.1111\/ctr.13597","article-title":"Renal cell carcinoma suspected at time of organ donation 2008-2016: a report of the OPTN ad hoc Disease Transmission Advisory Committee Registry","volume":"33","author":"Pavlakis","year":"2019","journal-title":"Clin Transpl"},{"key":"10.1016\/j.fjurol.2025.102960_bib0905","unstructured":"D\u2019Errico A, Malvi D, Mescoli C, Eccher A, Novelli L. Valutazione dell\u2019idoneit\u00e0 del donatore in relazione a patologie neoplastiche (tumori Solidi), Review n. 4 validated the 18.03.2025 (published the 24\/01\/2018), Centro Nazionale Trapianti, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161, Roma, Italy. Review n. 4 the 18.03.2025 ed."},{"key":"10.1016\/j.fjurol.2025.102960_bib0910","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00007890-199559040-00006","article-title":"Primary kidney tumors before and after renal transplantation","volume":"59","author":"Penn","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0915","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.purol.2020.04.030","article-title":"Recommandations fran\u00e7aises du Comit\u00e9 de transplantation de l\u2019association fran\u00e7aise d\u2019urologie (CTAFU)\u00a0: carcinome r\u00e9nal sur reins natifs chez le patient transplant\u00e9 r\u00e9nal ou en attente de transplantation","volume":"31","author":"Goujon","year":"2021","journal-title":"Prog Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0920","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41698-024-00532-x","article-title":"UroPredict: machine learning model on real-world data for prediction of kidney cancer recurrence (UroCCR-120)","volume":"8","author":"Margue","year":"2024","journal-title":"Precis Onc"},{"key":"10.1016\/j.fjurol.2025.102960_bib0925","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.urology.2005.11.020","article-title":"Prospective study of safety margins in partial nephrectomy: intraoperative assessment and contribution of frozen section analysis","volume":"67","author":"Timsit","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2025.102960_bib0930","first-page":"6778","article-title":"Is there a benefit to frozen section analysis at the time of partial nephrectomy?","volume":"20","author":"Sterious","year":"2013","journal-title":"Can J Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0935","first-page":"3353268","article-title":"Donor-derived urothelial carcinoma in renal transplant recipients","volume":"2022","author":"Qian","year":"2022","journal-title":"Case Rep Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0940","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-223087","article-title":"Urothelial carcinoma of an allograft ureter 10 years after deceased donor kidney transplantation","volume":"2018","author":"Gaughan","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.fjurol.2025.102960_bib0945","first-page":"354","article-title":"Female urothelial cell carcinoma in a failed kidney graft of a male recipient","volume":"75","author":"de Jongh","year":"2017","journal-title":"Neth J Med"},{"key":"10.1016\/j.fjurol.2025.102960_bib0950","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40425-016-0167-4","article-title":"Urothelial carcinoma of donor origin in a kidney transplant patient","volume":"4","author":"Michel Ortega","year":"2016","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.fjurol.2025.102960_bib0955","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/jjco\/hyu015","article-title":"Concurrent urothelial carcinoma in the renal pelvis of an allograft kidney and native recipient bladder: evidence of donor origin","volume":"44","author":"Takaoka","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0960","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/TP.0000000000000023","article-title":"Outcomes of kidney transplant tourism and risk factors for de novo urothelial carcinoma","volume":"98","author":"Tsai","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.fjurol.2025.102960_bib0965","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/ndt\/gfp612","article-title":"Urothelial carcinoma transmission via kidney transplantation","volume":"25","author":"Ferreira","year":"2010","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.fjurol.2025.102960_bib0970","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1399-0012.2008.00889.x","article-title":"Transfer of ureteral carcinoma in a transplanted kidney presenting by early stenosis of the proximal ureter","volume":"22","author":"Huurman VaL","year":"2008","journal-title":"Clin Transpl"},{"key":"10.1016\/j.fjurol.2025.102960_bib0975","doi-asserted-by":"crossref","first-page":"102742","DOI":"10.1016\/j.fjurol.2024.102742","article-title":"French AFU Cancer Committee Guidelines\u00a0-\u00a0Update 2024-2026: Non-muscle invasive bladder cancer (NMIBC)","volume":"34","author":"Roumigui\u00e9","year":"2024","journal-title":"Fr J Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0980","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0985","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0990","doi-asserted-by":"crossref","first-page":"102741","DOI":"10.1016\/j.fjurol.2024.102741","article-title":"Cancer Committee Guidelines\u00a0-\u00a0Update 2024-2026: muscle-invasive bladder cancer (MIBC)","volume":"34","author":"Roumigui\u00e9","year":"2024","journal-title":"Fr J Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib0995","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa2408154","article-title":"Perioperative durvalumab with neoadjuvant chemotherapy in operable bladder cancer","volume":"391","author":"Powles","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fjurol.2025.102960_bib1000","doi-asserted-by":"crossref","first-page":"102722","DOI":"10.1016\/j.fjurol.2024.102722","article-title":"French AFU Cancer Committee Guidelines\u00a0-\u00a0Update 2024-2026: upper urinary tract urothelial cancer (UTUC)","volume":"34","author":"Roumigui\u00e9","year":"2024","journal-title":"Fr J Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib1005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.euo.2022.04.003","article-title":"Oncologic surveillance after radical nephroureterectomy for high-risk upper tract urothelial carcinoma","volume":"5","author":"Martini","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.fjurol.2025.102960_bib1010","series-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay JEMLF","year":"2022"},{"key":"10.1016\/j.fjurol.2025.102960_bib1015","doi-asserted-by":"crossref","first-page":"114025","DOI":"10.1016\/j.ejca.2024.114025","article-title":"Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: a nationwide, population-based cohort study","volume":"202","author":"Wagner","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fjurol.2025.102960_bib1020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1200\/JCO.23.00959","article-title":"Prognostic factors for relapse in patients with clinical stage I testicular seminoma: a nationwide, population-based cohort study","volume":"42","author":"Wagner","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fjurol.2025.102960_bib1025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.euo.2023.10.014","article-title":"Prognostic factor risk groups for clinical stage I seminoma: an individual patient data analysis by the European association of urology testicular cancer guidelines panel and guidelines office","volume":"7","author":"Boormans","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.fjurol.2025.102960_bib1030","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.eururo.2014.07.001","article-title":"A nationwide cohort study of stage I seminoma patients followed on a surveillance program","volume":"66","author":"Mortensen","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib1035","doi-asserted-by":"crossref","first-page":"102718","DOI":"10.1016\/j.fjurol.2024.102718","article-title":"French AFU Cancer Committee Guidelines - Update 2024-2026: Testicular germ cell cancer","volume":"34","author":"Murez","year":"2024","journal-title":"Fr J Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib1040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.eururo.2016.07.013","article-title":"Conditional risk of relapse in surveillance for clinical stage I testicular cancer","volume":"71","author":"Nayan","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2025.102960_bib1045","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2013.53.5831","article-title":"Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort","volume":"32","author":"Daugaard","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fjurol.2025.102960_bib1050","first-page":"322","article-title":"Donor-derived testicular germ cell cancer in a heart transplant recipient.JACC","volume":"3","author":"Oerlemans","year":"2021","journal-title":"CardioOncol"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295039302500107X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295039302500107X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:02:48Z","timestamp":1767970968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S295039302500107X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":105,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S295039302500107X"],"URL":"https:\/\/doi.org\/10.1016\/j.fjurol.2025.102960","relation":{},"ISSN":["2950-3930"],"issn-type":[{"value":"2950-3930","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney transplantation from donors with cancer or history of cancer: Transplantation and cancerology committee of Association Fran\u00e7aise d\u2019Urologie guidelines (CTAFU\/CCAFU)","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fjurol.2025.102960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102960"}}